BSD Medical Corp. (NSDQ:BSDM) landed 510(k) clearance from the Food & Drug Administration for itsits MicroThermX microwave ablation system, MTX-180.
The Salt Lake City, Missouri-based cancer treatment device-maker said it optimized the MTX-180 system with higher power for interventional and surgical oncology. The device uses “synchronous phased array technology” to target microwave energy for soft-tissue ablation.
BSD said CE Mark approval for the MTX-18 0 system “is imminent.”
The Power Behind Enterprise EHR Software for Large Healthcare Systems
Enterprise EHR boosts scalability, interoperability, and governance for large healthcare systems.
In addition to winning FDA clearance for the microwave-powered tumor destroyer, the company also announced a stock sale to a pair of prior backers. BSD entered into a securities purchase deal with two institutional investors to sell 1,225,000 shares in a direct offering at $2.25 each, plus warrants for the purchase of 918,750 shares, according to a Securities and Exchange Commission filing.
BSD said the funds from the sale will be put towards product development, sales & marketing and general corporate purposes. The company said it will not use the proceeds of the offering to satisfy any existing debt, redeem any of its outstanding securities or settle any outstanding litigation.
The Massachusetts Medical Devices Journal is the online journal of the medical devices industry in the Commonwealth and New England, providing day-to-day coverage of the devices that save lives, the people behind them, and the burgeoning trends and developments within the industry.
Top 7 Modern AI-Powered EAP Providers for Global Workforces in 2026
Discover the top AI-powered EAP providers for 2026. Compare platforms like Kyan Health and Spring Health on triage speed, global reach, and clinical quality to transform workforce wellbeing.
This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.